BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250321T090000
DTEND;TZID=Europe/Stockholm:20250321T094000
DTSTAMP:20260421T140815
CREATED:20250221T143110Z
LAST-MODIFIED:20250227T154106Z
UID:181955-1742547600-1742550000@www.scilifelab.se
SUMMARY:Precision phenotyping in dilated cardiomyopathy
DESCRIPTION:Charlotta Ljungman\, Senior consultant \n\n\n\nThis Clinical talks has been rescheduled – from February 28 to March 21. Any prior registrations remains valid. \n\n\n\nCharlotta Ljungman is senior consultant and associate professor in cardiology working at Sahlgrenska University Gothenburg. \n\n\n\n\n\n\n\nHer research involves aspects of heart failure and cardiomyopathy and she is the founder of Sahlgrenska Cardiomyopathy Center. She is also the chair of the Swedish heart failure registry (Swede-HF) \n\n\n\nregister to receive zoom link\n\n\n\nAbstract \n\n\n\nPrecision phenotyping has been suggested to find new subtypes and biomarkers in heart failure and dilated cardiomyopathy (DCM)\, the most common cardiomyopathy\, and were the cause in 50% of the cases is unknown. Therefore\, the aim of this project is to combine proteomics and metabolomics to: \n\n\n\n\nUnderstand cardiac energy metabolism in heart failure and DCM.\n\n\n\nFind subtypes and biomarkers by multimodal precision phenotyping with proteomics and integration of data\n\n\n\n\nOnce established\, the precision phenotyping approach may allow identification of patients/subtypes at greatest risk\, find new biomarkers and allow intervention and personalized follow-up of high-risk individuals.  \n\n\n\nThe aim will be achieved by investigating cardiac energy metabolism (uptake and release) and proteomic profile in relation to cardiac function at rest and during exercise\, in patients in comparison to healthy controls.  Patients undergoing right heart catheterization (RHC) with the diagnosis of heart failure and DCM without metabolic disease are included in a prospective mechanistic case control study of cardiac energetics; the MEtabolic CHAracterization of patients with Dilated cardiomyopathy (MECHAD) study. Age and sex matched controls without heart failure undergoing electrophysiological examination are included. Arterial blood supply tissues and organs with oxygen and metabolites for energy and venous blood carry the metabolic by-products and carbon oxide from tissues and organs. This allows to calculate uptake and release of metabolites and oxygen through arteriovenous approach by simultaneous sampling in artery (to the heart) and the coronary sinus (from the heart) when performing RHC and calculate cardiac energy metabolism and collect samples for proteomics profiling. Patients undergo clinical examinations including medical history\, alcohol use disorders identification test\, Kansas City Cardiomyopathy Questionnaire\, ECG\, blood pressure\, Transthoracical echocardiography (TTE) and Cardiopulmonary exercise testing (CPET). All patients are followed for 12 months. \n\n\n\nClinical Talks returns with a new season! \n\n\n\nAfter seven successful seasons and over seventy dedicated speakers\, we are excited to continue showcasing the contributions of our diverse clinical\, academic\, and industry Life Science community. This season will feature ten insightful talks\, following our well-established format. \n\n\n\nThe overarching theme is “How to Achieve Feasible Implementation.” Sessions will be held monthly on Fridays from 09:00 to 09:30 am via Zoom\, with occasional exceptions. Each talk will be followed by an engaging Q&A session\, moderated by standing host Rikard Fred\, alongside a guest moderator with subject matter expertise to enrich the discussion. \n\n\n\nIn today’s rapidly evolving post-pandemic landscape\, it is crucial to explore how academic\, clinical\, and industry research—combined with technological advancements—can drive practical and sustainable solutions. Join us for an opportunity to gain fresh insights\, expand your knowledge\, and connect with experts shaping the future of Life Sciences! \n\n\n\nClinical Talks are organized by the SciLifeLab’s Precision Medicine Capability
URL:https://www.scilifelab.se/event/precision-phenotyping-in-dilated-cardiomyopathy/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
END:VCALENDAR